QUALITY CONTROL OF MEDICINAL PRODUCTS AS A LEGAL INSTITUTION: OBJECTIVES, METHODS, AND ISSUES OF NORMATIVE REGULATION

This article is devoted to the analysis of quality control of medicinal products as a key institution of legal regulation in the pharmaceutical sector. The objectives, tasks, and methods of control are examined, as well as issues related to the normative consolidation of this mechanism in national and international contexts. Particular attention is paid to the legal nature of quality control, its significance for protecting public health, ensuring the safety of the pharmaceutical market, and maintaining trust in the healthcare system. Based on an analysis of the legislative acts of the Republic of Uzbekistan, the Russian Federation, international WHO documents, and scientific literature, gaps in the legislation are identified, and possible ways to address them are proposed.